News

A technique that combines the ultrasensitivity of surface-enhanced Raman scattering (SERS) with a slippery surface invented by Penn State researchers will make it feasible to detect single molecules of a number of chemical and biological species from gaseous, liquid or solid samples.

Arquer’s high sensitivity, ELISA test in study for Bladder Cancer consisting of a six month, multi-centre 800 patient clinical trial.

Pfizer Inc. and Adaptive Biotechnologies Corporation have entered into a translational research collaboration to leverage next generation sequencing of the adaptive immune system to advance Pfizer’s growing immuno-oncology franchise.

A new study led by scientists at The Scripps Research Institute (TSRI) and St. Jude Children’s Research Hospital shows how a protein involved in cancer twists and morphs into different structures.

Don’t worry, science fiction fans, the machines aren’t taking over quite yet. It turns out humans still beat computers at reading and comprehending text.

Strengthens leadership in biosciences and genetic analysis.

OriGene Technologies have announced that they have been awarded a Phase II SBIR contract from the National Cancer Institute (NCI) to develop high-affinity, anti-peptide antibodies for mass-spectrometry-based serum biomarker detection/ quantification assays.

Exosome Diagnostics has announced the final close of its $60 million Series B financing.

Scientists at Imperial College London have discovered how flu viruses 'hijack' cell machinery when they infect the body.

Computer program scrambles genetic codes for production of repetitive DNA and synthetic molecules.